Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Cardiac Sciences
    • Hops compounds may...

    Hops compounds may improve metabolic syndrome by changing gut microbiota

    Written by Hina Zahid Published On 2019-12-02T19:15:00+05:30  |  Updated On 2 Dec 2019 7:15 PM IST
    Hops compounds may improve metabolic syndrome by changing gut microbiota

    Metabolic syndrome is a disease of the present-day world and according to an estimate, more than 35% of U.S. adults suffer from metabolic syndrome. It is highly correlated with obesity and cardiovascular risk. A patient is considered to have metabolic syndrome if he or she has at least three of the following conditions: abdominal obesity, high blood pressure, high blood sugar, low levels of “good” cholesterol, and high levels of triglycerides.


    Researchers at Oregon State University have found that compounds from hops may combat metabolic syndrome by changing the gut microbiome and altering the metabolism of acids produced in the liver. The findings of the research have been published in Molecular Nutrition and Food Research.


    Hop (Humulus lupulus Linnaeus) is a dioecious, perennial plant belonging to the Cannabaceae family of the Urticales order.


    The researchers hypothesized that improvements in obesity and metabolic syndrome are linked to changes in the composition of the gut microbiota, bile acid metabolism, intestinal barrier function and inflammation.


    Please also read -Living close to greenery reduces risk of metabolic syndrome, finds study


    The findings are a key advance in understanding how xanthohumol, a compound that contributes to hops' flavour, and its derivatives work. That is an important step toward improving the lives of the estimated 35% of U.S. adults who suffer from metabolic syndrome.



    The study builds on earlier research at OSU that found xanthohumol, often abbreviated to XN, and two hydrogenated derivatives, DXN and TXN, can likely improve cognitive and other functions in people with the syndrome.


    Please also read -Fenofibrate add on to statins reduces CV risk in metabolic syndrome: BMJ

    People are considered to have metabolic syndrome if they have at least two of the following conditions: abdominal obesity, high blood pressure, high blood sugar, low levels of "good" cholesterol and high levels of triglycerides.


    A diet high in saturated fat and refined sugars causes chronic low-grade inflammation that contributes to the development of metabolic syndrome; the syndrome is associated with cognitive dysfunction and dementia as well as being a major risk factor for cardiovascular disease and Type 2 diabetes.


    In the previous study, testing in a mouse model showed that XN, DXN, and TXN improve glucose intolerance, insulin resistance and sensitivity to leptin—a hormone that tells you to feel full when you have eaten enough and also helps regulate energy expenditure. All of these changes are thought to be beneficial in the fight against metabolic syndrome.


    In the most recent research, laboratory animals were given a high-fat diet exclusively, or a high-fat diet that included XN, TXN or DXN. Scientists then measured the compounds' effects on bile acids—bile is a fluid produced by the liver that helps with the digestion of fats—tissue inflammation and gut microbiome composition.


    Results show that each of the hops compounds decreased the amount and diversity of microbes, reduced inflammation and changed bile acid metabolism—there was a reduction in secondary bile acid production and an increase of conjugated bile acids, which are indicators of improved energy metabolism, glucose metabolism and cholesterol metabolism.


    "Changes in gut microbiota and bile acid metabolism seem to explain at least partially why XN and its derivatives lead to improvements in obesity and other aspects of metabolic syndrome," said the study's corresponding author, Adrian Gombart, professor of biochemistry and biophysics in the College of Science and a principal investigator at OSU's Linus Pauling Institute. "But this is not necessarily causing and effect—we need to know which changes to the microbiota are beneficial."


    Collaborator Fred Stevens, professor of pharmaceutical sciences in the OSU College of Pharmacy and also a principal investigator at the Linus Pauling Institute, found it surprising that the benefits were accompanied by a decrease rather than an increase in microbiome diversity.


    Gombart noted that the hops compounds have previously been shown to have antimicrobial properties, "so they may be killing off certain bugs that aren't beneficial and preserving other ones that are."


    Stevens added: "And further research will try to determine what the compounds are doing directly to the body in addition to what they're doing through the gut microbiota. These compounds must be having some direct effect on the body through their specific molecular size and shape."


    Molecular Nutrition & Food Research

    For more details click on the link: DOI: 10.1002/mnfr.201900789
    Fred Stevensmetabolic syndromemicrobiome diversityMolecular Nutrition and Food ResearchOregon State University
    Source : Molecular Nutrition and Food Research

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Hina Zahid
    Hina Zahid
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok